The European Society of Cardiology (ESC) is dedicated to promoting cardiovascular (CV) health and minimizing the occurrence of cardiovascular diseases throughout Europe. As a founding member of the European Alliance for Cardiovascular Health (EACH), the ESC is advocating for European and National Cardiovascular Health Plans which would include a cardiovascular and diabetes health check as part of a screening process for citizens.
In line with this call for public health diagnosis of CV health, the ESC is committed to raising awareness on the need for actions and proposes to offer complimentary tests to delegates at ESC Congress 2026 from 28-31 August 2026 in Munich, Germany.
The primary objective of the study is to screen the CV risk among the ESC Annual Congress 2026 attendees with a focus on healthcare professionals (HCP) and to stratify by primary or secondary prevention.
All attendees including healthcare professionals (doctors, nurses, etc.) attending the ESC Congress 2026 from 28 to 31 August 2026
Subjects who declare that they are able to understand and give informed consent in English
Adult subjects (≥ 18 years of age)
Subjects not willing to provide his/her consent to participate in the study.
Subjects who are not suitable candidates for blood extraction.
All attendees including healthcare professionals (doctors, nurses, etc.) attending the ESC Congress 2026 from 28 to 31 August 2026
Cohort
Prospective
Capillary blood draw
Biological/VaccineCapillary blood draw to assess several cardiovascular risk markers
Questionnaire and Physical Exam
BehavioralWaist circumference and blood pressure measurements
Urine sample
Biological/VaccineUrine sample
Questionnaire and Physical Exam
BehavioralQuestionnaire about lifestyle habits and medical history
Second Manifestations or Arterial Disease (SMART) risk score in patients with established cardiovascular diseases (CVD) at baseline
Systemic Coronary Risk Evaluation 2 (SCORE2) score in patients without established CVD at baseline
Level of agreement between self-perceived cardiovascular risk category and objectively assessed cardiovascular risk category based on the SCORE2 or SMART algorithm
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
